GE Healthcare
Anaesthesia Drug Delivery
Patient
Care
Anaesthesia
Drug
Delivery
Ultrasound guided
regional blocks
Precise delivery and
measurement
Rapid wash-in,
rapid wash-out
Workflow
Preparing you for the most
pressing challenges
Whether you practice inhalational anaesthesia,
intravenous anaesthesia or regional
anaesthesia, it is important to optimize the
delivery of the volatile, hypnotic, and opiate
drugs to the patient. GE’s anaesthesia drug
delivery solutions are specifically designed to
assist you with this vital task.
Uncompromised
ventilation
A platform for
the future
Anaesthesia
Drug Delivery
Predictive PK/PD
drug modeling
Drug effects
Patient
Agent
O
2
Digital monitoring
and flow control
Precision and safety
Et Control** continuously adjusts according
to your patient’s uptake, while end-tidal
oxygen is maintained at 25% or higher
End Tidal Control**
Target control for volatile anaesthesia and patient oxygen
End Tidal (Et) Control** helps maintain patient’s end-tidal
agent and oxygen settings. Regardless of changes in
patient’s hemodynamic and metabolic status, agent and
oxygen levels are automatically adjusted to targeted
end-tidal levels.
1
Et Agent
Et O
2
Agent delivery optimisation
Et Control** helps optimize end-tidal oxygen
and agent levels delivered
Target control made simple
We didn’t invent volatile TCA…
but we got it right
Potential to reduce your costs
When Et Control** is enabled at its default
settings it may lower agent consumption
due to reduced flow rates
Et Control** Enablers
Innovation and performance by design
Digital Gas Delivery
Digital control of the electronic gas mixer is a
cornerstone of End Tidal (Et) Control**
Digital Vapourizer
Maintenance-free vapourisers with digital vapour
delivery to optimise agent delivery, reduce agent
wastage and reduce environmental pollution
Time to reach the target concentrations are statistically significantly shorter with Avance* than
with Primus® on all saturation and washout profiles
2
Advanced Breathing System
Exceptional breathing circuit kinetics enables
rapid wash-in and wash-out profiles to optimise
agent and oxygen delivery
Aespire*, Avance and Aisys* utilize the same ABS 2,7 litre breathing circuit.
Avance, with a reduced volume breathing circuit (2,7litres versus Primus’ 4,5litres) mainly
through excluding manual circuit (balloon gas mixer) during mechanical ventilation; moreover
tubular geometry of the breathing circuit generates less turbulences and allows faster
sevoflurane saturation and washout
3